Yuen Tai Pharmaceuticals LIMITED
Company Profile
YUEN TAI PHARMACEUTICALS LIMITED is located at Rm 601-603 6/F Goodluck Indl Ctr, 808 Lai Chi Kok Rd, LAI CHI KOK, KOWLOON, HONG KONG. Operating in the Whol drugs/sundries industry, the company is registered as a corporation under the company number 392545.
Yuen Tai Pharmaceuticals LIMITED
Rm 601-603 6/F Goodluck Indl Ctr 808 Lai Chi Kok Rd, , Lai Chi Kok
392545
Corporation
1992
Whol drugs/sundries
Yuen Tai Pharmaceuticals LIMITED
Rm 601-603 6/F Goodluck Indl Ctr 808 Lai Chi Kok Rd, , Lai Chi Kok
392545
Corporation
1992
Whol drugs/sundries
The revenue of Yuen Tai Pharmaceuticals LIMITED is $5.4 million
Yuen Tai Pharmaceuticals LIMITED: Revenue from 2017 to 2024
Revenue of YUEN TAI PHARMACEUTICALS LIMITED: This data presents the revenue of YUEN TAI PHARMACEUTICALS LIMITED from 1995 to 1995. In the fiscal year 1995, YUEN TAI PHARMACEUTICALS LIMITED recorded a revenue of $2,170,646.17, showcasing its financial growth over recent years.
Revenue per year in USD ($)
Top 5 companies in revenue in Drugs, Drug Proprietaries, and Druggists' Sundries Worldwide
Company name | Sales |
---|---|
Cencora, Inc. | $262.2 billion |
Cardinal Health, Inc. | $205.0 billion |
McKesson Corporation | $276.7 billion |
PHOENIX Pharmahandel GmbH & Co KG | $38.6 billion |
Pfizer Service Company | $42.4 billion |
The number of employees of Yuen Tai Pharmaceuticals LIMITED is 5-9
Yuen Tai Pharmaceuticals LIMITED: Employees from 2017 - 2024
Employees at YUEN TAI PHARMACEUTICALS LIMITED: YUEN TAI PHARMACEUTICALS LIMITED now employs 8 people, reflecting the company’s significant presence.
Number of employees from 2017 to 2024
Global B2B Data in Bulk
Access the company database that sets the standard in scale and accuracy. Our massive B2B database covers all active companies worldwide, curated from trusted local sources. Delivered in bulk as CSV files.
The Industry of Yuen Tai Pharmaceuticals LIMITED is Drugs, Drug Proprietaries, and Druggists' Sundries
Yuen Tai Pharmaceuticals LIMITED Industry Data:
Industry of YUEN TAI PHARMACEUTICALS LIMITED: YUEN TAI PHARMACEUTICALS LIMITED operates in the Whol drugs/sundries industry, which falls under SIC Code 5122
Industry Statistics By Sic Code
Yuen Tai Pharmaceuticals LIMITED is operating in Sic Code:
Drugs, Drug Proprietaries, and Druggists' Sundries (5122) - Representation of companies operating in Australia/Asia and Hong Kong
919015
0.26% of companies worldwide
6897
0.36% of companies in HONG KONG
There are 919015 companies operating in this industry worldwide.
Buy in BulkBold Platform
The Bold platform provides instant access to verified data from active companies in 1,500 industries across 200+ countries, enabling users to find leads and download company lists in Excel.
Yuen Tai Pharmaceuticals LIMITED is owned by MORNING GOLD MEDICINE COMPANY LIMITED, which owns 3 companies Worldwide
Among the companies owned by MORNING GOLD MEDICINE COMPANY LIMITED are: Shijianle Real Estate Management (Shenzhen) Co., Ltd., located in Shenzhen, CHINA YUEN TAI PHARMACEUTICALS LIMITED, located in LAI CHI KOK, HONG KONG MORNING GOLD MEDICINE COMPANY LIMITED, located in CHEUNG SHA WAN, HONG KONG.
Company Type
Yuen Tai Pharmaceuticals LIMITED is registered as
153647093
44.07% of companies
1453130
75.43% of companies in HONG KONG
Bold Hierarchy
The Bold platform is your resource for Company Hierarchy Data, featuring insights on all companies connected across 200+ countries. Our database provides essential information about corporate structures, chains, and groups, empowering you to make informed, data-driven decisions.

Connect with Key Decision Makers at Yuen Tai Pharmaceuticals LIMITED
Email and Call Top Yuen Tai Pharmaceuticals LIMITED Contacts
YUEN TAI PHARMACEUTICALS LIMITED has a CEO registered at the official local trade register in HONG KONG. With 5 key contacts and decision makers, including CIOs, CFOs, and HR managers, YUEN TAI PHARMACEUTICALS LIMITED provides high-quality, verified communication with primary decision makers.
Unlock Access to Key Personnel Contact Information on the Bold Platform Today!